Application of ET-Kyoto solution in clinical lung transplantation.
Application of ET-Kyoto solution in clinical lung transplantation.
复制标题
ET-Kyoto溶液在临床肺移植中的应用
DOI：
10.1016/s0003-4975(03)01036-1
复制
发表时间：
2004
期刊：
影响因子：
--
通讯作者：
H. Wada
中科院分区：
文献类型：
--
作者：
M. Omasa;S. Hasegawa;T. Bando;N. Hanaoka;T. Yoshimura;T. Nakamura;H. Wada
我们开发了一种新的器官保存液，称为含细胞外型海藻糖的京都（ET-京都）溶液。ET-Kyoto液已应用于临床肺移植。患者是一名49岁女性，患有弥漫性泛细支气管炎。她接受了活体供者的双侧肺叶移植。用ET-Kyoto溶液冲洗每个肺叶。再灌注后，吸入100%氧气时PaO2> 500 Torr。移植后病程平稳。尽管本病例报告的缺血时间相对较短，但ET-Kyoto溶液在临床肺移植中应用是可行和安全的。
We have developed a new organ preservation solution called extracellular-type trehalose-containing Kyoto (ET-Kyoto) solution. ET-Kyoto solution has been applied in clinical lung transplantation. The patient was a 49-year-old woman with diffuse panbronchiolitis. She underwent bilateral lobar lung transplantation from living donors. Each lobe was flushed with ET-Kyoto solution. After reperfusion, Pao2with inhalation of 100% oxygen was more than 500 Torr. Posttransplantation course was uneventful. Despite the relatively short ischemic time of this case report, ET-Kyoto solution may be feasible and safely applied in clinical lung transplantation.